Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 48% ± 16% | |
| endothelial cell | 5 studies | 22% ± 4% | |
| deuterosomal cell | 4 studies | 22% ± 1% | |
| epithelial cell | 4 studies | 38% ± 14% | |
| GABAergic neuron | 4 studies | 26% ± 7% | |
| glutamatergic neuron | 4 studies | 30% ± 9% | |
| astrocyte | 4 studies | 23% ± 6% | |
| CD8-positive, alpha-beta T cell | 4 studies | 22% ± 7% | |
| hematopoietic precursor cell | 3 studies | 23% ± 6% | |
| plasma cell | 3 studies | 30% ± 12% | |
| erythroblast | 3 studies | 31% ± 10% | |
| dendritic cell | 3 studies | 25% ± 2% | |
| abnormal cell | 3 studies | 23% ± 5% | |
| basal cell | 3 studies | 29% ± 12% | |
| interneuron | 3 studies | 26% ± 9% | |
| neuron | 3 studies | 25% ± 7% | |
| natural killer cell | 3 studies | 20% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 1306.12 | 180 / 180 | 100% | 34.66 | 430 / 430 |
| skin | 100% | 2430.71 | 1809 / 1809 | 100% | 33.55 | 471 / 472 |
| uterus | 100% | 1791.54 | 170 / 170 | 100% | 45.05 | 458 / 459 |
| breast | 100% | 1613.13 | 459 / 459 | 100% | 33.14 | 1114 / 1118 |
| lung | 100% | 1543.74 | 577 / 578 | 100% | 35.25 | 1151 / 1155 |
| prostate | 100% | 1244.04 | 245 / 245 | 99% | 26.57 | 498 / 502 |
| thymus | 100% | 1427.24 | 653 / 653 | 99% | 19.18 | 600 / 605 |
| brain | 99% | 975.06 | 2618 / 2642 | 100% | 27.15 | 705 / 705 |
| bladder | 100% | 1619.86 | 21 / 21 | 99% | 35.69 | 499 / 504 |
| esophagus | 100% | 1553.59 | 1445 / 1445 | 99% | 25.74 | 181 / 183 |
| intestine | 100% | 1325.38 | 965 / 966 | 99% | 31.93 | 520 / 527 |
| stomach | 99% | 1023.39 | 357 / 359 | 99% | 26.93 | 283 / 286 |
| pancreas | 99% | 712.05 | 324 / 328 | 99% | 23.41 | 176 / 178 |
| kidney | 100% | 1544.10 | 89 / 89 | 97% | 17.75 | 872 / 901 |
| liver | 100% | 840.63 | 225 / 226 | 92% | 13.31 | 374 / 406 |
| adrenal gland | 100% | 1540.76 | 258 / 258 | 88% | 12.27 | 203 / 230 |
| adipose | 100% | 1557.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 58.46 | 29 / 29 |
| spleen | 100% | 1881.80 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 47.62 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 26.83 | 1 / 1 |
| blood vessel | 100% | 1085.19 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 900.13 | 793 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 19.72 | 79 / 80 |
| heart | 98% | 1362.47 | 841 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 92% | 1676.83 | 855 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032508 | Biological process | DNA duplex unwinding |
| GO_0006281 | Biological process | DNA repair |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0045995 | Biological process | regulation of embryonic development |
| GO_2000779 | Biological process | regulation of double-strand break repair |
| GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
| GO_0045739 | Biological process | positive regulation of DNA repair |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0006282 | Biological process | regulation of DNA repair |
| GO_1904874 | Biological process | positive regulation of telomerase RNA localization to Cajal body |
| GO_0060382 | Biological process | regulation of DNA strand elongation |
| GO_1904507 | Biological process | positive regulation of telomere maintenance in response to DNA damage |
| GO_0051301 | Biological process | cell division |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0042981 | Biological process | regulation of apoptotic process |
| GO_0000492 | Biological process | box C/D snoRNP assembly |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0050821 | Biological process | protein stabilization |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0000723 | Biological process | telomere maintenance |
| GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
| GO_0033044 | Biological process | regulation of chromosome organization |
| GO_0006310 | Biological process | DNA recombination |
| GO_0006275 | Biological process | regulation of DNA replication |
| GO_0051726 | Biological process | regulation of cell cycle |
| GO_0000812 | Cellular component | Swr1 complex |
| GO_0071339 | Cellular component | MLL1 complex |
| GO_0000786 | Cellular component | nucleosome |
| GO_1990062 | Cellular component | RPAP3/R2TP/prefoldin-like complex |
| GO_0016020 | Cellular component | membrane |
| GO_0005813 | Cellular component | centrosome |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0035267 | Cellular component | NuA4 histone acetyltransferase complex |
| GO_0016363 | Cellular component | nuclear matrix |
| GO_0120293 | Cellular component | dynein axonemal particle |
| GO_0101031 | Cellular component | protein folding chaperone complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0097255 | Cellular component | R2TP complex |
| GO_1990904 | Cellular component | ribonucleoprotein complex |
| GO_0031011 | Cellular component | Ino80 complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0017025 | Molecular function | TBP-class protein binding |
| GO_0043531 | Molecular function | ADP binding |
| GO_0001094 | Molecular function | TFIID-class transcription factor complex binding |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0003678 | Molecular function | DNA helicase activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0051117 | Molecular function | ATPase binding |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| Gene name | RUVBL1 |
| Protein name | RuvB-like helicase (EC 3.6.4.12) RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein) (ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238) (NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha) (TAP54-alpha) |
| Synonyms | TIP49A TIP49 INO80H NMP238 |
| Description | FUNCTION: Possesses single-stranded DNA-stimulated ATPase and ATP-dependent DNA helicase (3' to 5') activity; hexamerization is thought to be critical for ATP hydrolysis and adjacent subunits in the ring-like structure contribute to the ATPase activity . Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A . This modification may both alter nucleosome-DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription . This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair . The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage . Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome . Proposed core component of the chromatin remodeling INO80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding . Plays an essential role in oncogenic transformation by MYC and also modulates transcriptional activation by the LEF1/TCF1-CTNNB1 complex . Essential for cell proliferation . May be able to bind plasminogen at cell surface and enhance plasminogen activation . . FUNCTION: Proposed core component of the chromatin remodeling Ino80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding. . FUNCTION: Proposed core component of the chromatin remodeling Ino80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding. . FUNCTION: Proposed core component of the chromatin remodeling Ino80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding. . FUNCTION: Proposed core component of the chromatin remodeling Ino80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding. . FUNCTION: Proposed core component of the chromatin remodeling Ino80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding. . |
| Accessions | ENST00000585057.5 H7C4G5 H7C4I3 J3QLR1 ENST00000322623.10 [Q9Y265-1] ENST00000464873.5 ENST00000472125.5 ENST00000478892.1 E7ETR0 Q9Y265 B5BUB1 |